80.59MMarket Cap-1063P/E (TTM)
1.690High1.652Low35.01KVolume1.670Open1.660Pre Close58.73KTurnover0.25%Turnover RatioLossP/E (Static)48.26MShares5.48052wk High0.52P/B23.49MFloat Cap1.02052wk Low--Dividend TTM14.07MShs Float37.610Historical High--Div YieldTTM2.31%Amplitude1.020Historical Low1.677Avg Price1Lot Size
Ikena Oncology Stock Forum
Ikena Oncology Announces Strategic Update
Ikena Oncology announced they are discontinuing the development of IK-930, their TEAD1-selective Hippo pathway inhibitor. The company will continue the clinical development of IK-595, a MEK-RAF molecular glue showing promising PK and PD data in RAS and RAF mutant cancers. Ikena ended Q1 with $157.3 million in cash and is projecting $110-$120 million by year-end 2024. The company is exploring strategic options, including part...
• $La-Z-Boy(LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US)$)
• $Ikena Oncology(IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
• $Gol Intelligent Airlines(GOL.US)$ +18.5% (earnings report)
• $LendingClub(LC.US)$ +16.9% (earnings report)
• $MaxLinear(MXL.US)$ +15.9% (earnings report)
• $Meta Platforms(FB.US)$ +15.8% (Facebook revenue slows but user gains boost stock)
• $Noodles & Co(NDLS.US)$ +15.2% (earnings report)
• $Avnet(AVT.US)$ +11.2% (earnings report)
• $Qualcomm(QCOM.US)$ +6.8% (Qualcomm reports earnings as smartphone market weakens)
• $Vale SA(VALE.US)$ +5.3% (an...
No comment yet